PHAXIAM Therapeutics SA

1.5860

29-November-24 11:20:06

15 minutes delayed

Stocks

-0.0060

-0.38%

Today's range

1.5860 - 1.5860

ISIN

FR001400K4B1

Source

Cboe

PHAXIAM Therapeutics announces intention to voluntary delist American Depositary Shares from The Nasdaq Capital Market

20 Feb 2024 16:05:00 By Nasdaq GlobeNewswire
Monthly information related to total number of voting rights and shares composing the share capital - January 31, 2024

06 Feb 2024 16:05:00 By Nasdaq GlobeNewswire
PHAXIAM Therapeutics announces its cash position at the end of 2023 and its financial calendar for 2024

18 Jan 2024 16:05:00 By Nasdaq GlobeNewswire
Monthly information related to total number of voting rights and shares composing the share capital - December 31, 2023

03 Jan 2024 16:05:00 By Nasdaq GlobeNewswire
Monthly information related to total number of voting rights and shares composing the share capital - November 30, 2023

06 Dec 2023 16:05:00 By Nasdaq GlobeNewswire
PHAXIAM Provides Business and Financial Update for the Third Quarter of 2023

14 Nov 2023 16:05:00 By Nasdaq GlobeNewswire
Monthly information related to total number of voting rights and shares composing the share capital _ October 31, 2023

07 Nov 2023 12:00:00 By Nasdaq GlobeNewswire
PHAXIAM Therapeutics obtains authorizations to launch its phase 1 study in endocarditis infections caused by Staphylococcus aureus

24 Oct 2023 16:05:00 By Nasdaq GlobeNewswire
TP ICAP Midcap initiates coverage of PHAXIAM Therapeutics with a “Buy” recommendation

23 Oct 2023 16:05:00 By Nasdaq GlobeNewswire
Monthly information related to total number of voting rights and shares composing the share capital _September 30, 2023

23 Oct 2023 12:00:00 By Nasdaq GlobeNewswire

<<
<
1
2
>

I Agree NetDania's website uses cookies. By continuing browsing our website, you agree to our Cookie Policy, Privacy Policy and Terms and Conditons.